NCT01901588View on ClinicalTrials.gov

Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2016

Conditions
StrabismusDelirium on EmergencePediatric Disorders
Interventions
DRUG

Dexmedetomidine

intravenous dose of dexmedetomidine 0.3 mcg/kg over 5 minutes

OTHER

Placebo

intraoperative dose of intravenous placebo

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01901588 - Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery | Biotech Hunter | Biotech Hunter